Top Markets
Coin of the day
Healios K.K. Healios K.K.

Healios K.K.

4593
Kedudukan dalam Saham #17173
Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011,... Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011, specializes in the discovery, development, manufacturing, and commercialization of advanced cell and regenerative medical therapies. The company operates across key markets including Japan, Europe, and the United States. Its robust pipeline features several cellular and tissue-based products, such as HLCR011 and HLCR012, which are induced pluripotent stem cell (iPSC)-derived regenerative medicines aimed at treating age-related macular degeneration. Another iPSC-based therapy, HLCL041, is being developed for metabolic liver disease. Furthermore, Healios is progressing HLCM051, a regenerative treatment designed for ischemic stroke and acute respiratory distress syndrome, alongside HLCN061 for solid tumor indications. The company also maintains a joint research partnership with Hyogo Medical University, focusing on eNK cell-based cancer immunotherapies to combat mesothelioma. Healios K.K. adopted its current name in September 2013, having previously operated under the name Retina Institute Japan, K.K.
Harga Saham
$1.89
Modal Pasaran
$254.55M
Perubahan (1 hari)
-2.03%
Perubahan (1 tahun)
-48.53%
Negara
JP
Perdagangan Healios K.K. (4593)

Kategori

Sejarah harga saham bagi Healios K.K. (4593)
Harga penutupan tertinggi: $1.91 pada 2026-09-01

Harga penutupan terendah: $12.24 pada 2015-06-01
Sejarah harga saham Healios K.K. dari 2015 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 10.25%
2025 88.62%
2024 -2.29%
2023 -42.34%
2022 -81.62%
2021 -40.66%
2020 45.21%
2019 -16.02%
2018 2.08%
2017 -12.10%
2016 85.34%
2015 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$550.65 37.32%
US
$1.05K 48.27%
NL
$148.50 513.89%
US
$122.21 -10.03%
AU
$763.69 9.05%
CH